Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of diabetes on long-term outcome in STEMI patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors and BMS or DES.
De Luca G, Sauro R, Varricchio A, Capasso M, Lanzillo T, Manganelli F, Mariello C, Siano F, Carbone G, Pagliuca MR, Rosato G, Di Lorenzo E. De Luca G, et al. Among authors: di lorenzo e. J Thromb Thrombolysis. 2010 Aug;30(2):133-41. doi: 10.1007/s11239-009-0420-5. J Thromb Thrombolysis. 2010. PMID: 19921102 Clinical Trial.
Short and long-term benefits of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
De Luca G, Valgimigli M, Spaulding C, Menichelli M, Brunner-La Rocca HP, van der Hoeven BL, Di Lorenzo E, Diaz de la Llera LS, Pasceri V, Pittl U, Percoco G, Violini R, Stone GW. De Luca G, et al. Among authors: di lorenzo e. J Thromb Thrombolysis. 2009 Aug;28(2):200-10. doi: 10.1007/s11239-009-0305-7. Epub 2009 Feb 4. J Thromb Thrombolysis. 2009. PMID: 19190859
Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial.
Di Lorenzo E, Sauro R, Varricchio A, Capasso M, Lanzillo T, Manganelli F, Carbone G, Lanni F, Pagliuca MR, Stanco G, Rosato G, Suryapranata H, De Luca G. Di Lorenzo E, et al. JACC Cardiovasc Interv. 2014 Aug;7(8):849-56. doi: 10.1016/j.jcin.2014.02.016. JACC Cardiovasc Interv. 2014. PMID: 25147029 Free article. Clinical Trial.
Impact of diabetes on the benefits from everolimus-eluting stent as compared to first-generation drug-eluting stent in patients with ST elevation myocardial infarction.
De Luca G, Sauro R, Capasso M, Lanzillo T, Manganelli F, Carbone G, Lanni F, Pagliuca MR, Palmieri V, Serino V, Rosato G, Suryapranata H, Di Lorenzo E. De Luca G, et al. Among authors: di lorenzo e. Diab Vasc Dis Res. 2015 Sep;12(5):306-14. doi: 10.1177/1479164115592252. Epub 2015 Jul 6. Diab Vasc Dis Res. 2015. PMID: 26150193 Free article. Clinical Trial.
Long-term results of the randomized comparison of everolimus-eluting stents and sirolimus-eluting stent in patients with ST elevation myocardial infarction (RACES-MI trial).
Di Lorenzo E, Sauro R, Capasso M, Lanni F, Lanzillo T, Carbone G, Manganelli F, Palmieri V, Serino V, Pagliuca MR, Rosato G, Suryapranata H, De Luca G. Di Lorenzo E, et al. Int J Cardiol. 2016 Jan 1;202:177-82. doi: 10.1016/j.ijcard.2015.08.123. Epub 2015 Aug 16. Int J Cardiol. 2016. PMID: 26397405 Clinical Trial.
Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial.
Di Lorenzo E, Sauro R, Varricchio A, Carbone G, Cortese G, Capasso M, Lanzillo T, Manganelli F, Mariello C, Siano F, Pagliuca MR, Stanco G, Rosato G, De Luca G. Di Lorenzo E, et al. Circulation. 2009 Sep 15;120(11):964-72. doi: 10.1161/CIRCULATIONAHA.108.830372. Epub 2009 Aug 31. Circulation. 2009. Retraction in: Circulation. 2010 Mar 2;121(8):e228. doi: 10.1161/CIR.0b013e3181d70edb PMID: 19720939 Retracted. Clinical Trial.
Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial.
Di Lorenzo E, Sauro R, Varricchio A, Capasso M, Lanzillo T, Manganelli F, Mariello C, Siano F, Pagliuca MR, Stanco G, Rosato G, De Luca G. Di Lorenzo E, et al. Am Heart J. 2009 Oct;158(4):e43-50. doi: 10.1016/j.ahj.2009.03.016. Am Heart J. 2009. PMID: 19781402 Clinical Trial.
Impact of diabetes on long-term outcome after primary angioplasty: insights from the DESERT cooperation.
De Luca G, Dirksen MT, Spaulding C, Kelbæk H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Diaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Suryapranata H, Stone GW; DESERT cooperation. De Luca G, et al. Among authors: di lorenzo e. Diabetes Care. 2013 Apr;36(4):1020-5. doi: 10.2337/dc12-1507. Epub 2012 Dec 28. Diabetes Care. 2013. PMID: 23275351 Free PMC article.
111 results